Ductal Carcinoma in Situ of the Breast
September 2021 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Ductal Carcinoma in Situ of the Breast abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Ductal Carcinoma in Situ of the Breast. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Ductal Carcinoma in Situ of the Breast. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Ductal Carcinoma in Situ of the Breast every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI.
Authors:Lai HW, Chang YL, Chen ST, Chang YJ, Wu WP, Chen DR, Kuo SJ, Liao CY, Wu HK
Institution:Endoscopic & Oncoplastic Breast Surgery Center, Changhua Christian Hospital, 135 Nanxiao Street, Changhua, 500, Taiwan. hwlai650420@yahoo.com.tw. Changhua, 500, Taiwan. hwlai650420@yahoo.com.tw. Changhua, 500, Taiwan. hwlai650420@yahoo.com.tw. Street, Changhua, 500, Taiwan. hwlai650420@yahoo.com.tw. Taiwan. hwlai650420@yahoo.com.tw. hwlai650420@yahoo.com.tw. hwlai650420@yahoo.com.tw. hwlai650420@yahoo.com.tw. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. hwlai650420@yahoo.com.tw. hwlai650420@yahoo.com.tw. Taiwan. hwlai650420@yahoo.com.tw. Changhua, 500, Taiwan. Changhua, 500, Taiwan. Changhua, 500, Taiwan. 135 Nanxiao Street, Changhua, 500, Taiwan. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. 500, Taiwan. Nanxiao Street, Changhua, 500, Taiwan. Changhua, 500, Taiwan. Changhua, 500, Taiwan. Changhua, 500, Taiwan. Changhua, 500, Taiwan. 500, Taiwan. 500, Taiwan.
Journal:World J Surg Oncol. 2021 Sep 1;19(1):263. doi: 10.1186/s12957-021-02336-w.

2:Superficial margins in skin sparing and nipple sparing mastectomies for DCIS: A margin of potential concern.
Authors:Tramm T, Christiansen P, Offersen BV, Madsen KB, Poortmans P, Kaidar-Person O
Institution:Department of Pathology, Aarhus University Hospital, Denmark. Electronic address: tramm@oncology.au.dk. Medicine and Health Sciences, Wilrijk-Antwerp, Belgium. GROW-School for Oncology and Developmental Biology or GROW (Maastro), Maastricht University, Maastricht, The Netherlands.
Journal:Radiother Oncol. 2021 Aug;161:177-182. doi: 10.1016/j.radonc.2021.06.018. Epub 2021 Jun 15.

3:Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?
Authors:Livingston-Rosanoff D, Trentham-Dietz A, Hampton JM, Newcomb PA, Wilke LG
Institution:Division of Surgical Oncology, Department of Surgery, University of Wisconsin, 600 Highland Ave, Madison, WI, 53792, USA. livingstonrosanoff@surgery.wisc.edu. Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA. Highland Ave, Madison, WI, 53792, USA.
Journal:Breast Cancer Res Treat. 2021 Sep;189(2):463-470. doi: 10.1007/s10549-021-06278-5. Epub 2021 Jun 15.

4:Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Authors:Canelo-Aybar C, Taype-Rondan A, Zafra-Tanaka JH, Rigau D, Graewingholt A, Lebeau A, Pérez Gómez E, Rossi PG, Langedam M, Posso M, Parmelli E, Saz-Parkinson Z, Alonso-Coello P
Institution:CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. ccanelo@santpau.cat. Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antonio María Claret 167, 08025, Barcelona, Spain. ccanelo@santpau.cat. Síntesis de Evidencias en Salud, Lima, Peru. Heredia, Lima, Peru. Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antonio María Claret 167, 08025, Barcelona, Spain. Germany. Amsterdam Public Health Institute, Amsterdam, Netherlands. Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antonio María Claret 167, 08025, Barcelona, Spain. Institute), Barcelona, Spain.
Journal:Eur Radiol. 2021 Aug;31(8):5880-5893. doi: 10.1007/s00330-021-07873-2. Epub 2021 May 30.

5:DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS.
Authors:Rakovitch E, Parpia S, Koch A, Grimard L, Soliman H, Stevens C, Perera F, Kong I, Senthelal S, Anthes M, Wiebe E, Cao J, Goldberg M, Smith S, Spadafora L, Whelan TJ
Institution:Sunnybrook Health Sciences Centre, University of Toronto, T Wing 2075 Bayview Avenue, Toronto, ON, Canada. eileen.rakovitch@sunnybrook.ca. Canada. Avenue, Toronto, ON, Canada. Canada. Canada. Canada. Canada. whelan@hhsc.ca.
Journal:Breast Cancer Res Treat. 2021 Jul;188(1):133-139. doi: 10.1007/s10549-021-06187-7. Epub 2021 Apr 8.

6:Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Authors:Shin YD, Lee HM, Choi YJ
Institution:Department of Anesthesiology and Pain Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea. Department of Surgery, Chungbuk National University Hospital, Chungbuk National University College of Medicine, 1 Chungdae-ro, Seowon-gu, Cheongju-si, Chungcheongbuk-do, 28644, Republic of Korea. choiyj@chungbuk.ac.kr.
Journal:BMC Surg. 2021 Mar 22;21(1):159. doi: 10.1186/s12893-021-01170-x.

7:Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery.
Authors:Bartram A, Gilbert F, Thompson A, Mann GB, Agrawal A
Institution:University of Cambridge, School of Clinical Medicine, Cambridge, CB2 0SP, UK. Campus, Cambridge, CB2 0QQ, UK. Houston, TX 77030, USA. Parkville, 3050, Australia. Campus, Cambridge, CB2 0QQ, UK. Electronic address: amit.agrawal2@nhs.net.
Journal:Cancer Treat Rev. 2021 Mar;94:102158. doi: 10.1016/j.ctrv.2021.102158. Epub 2021 Feb 2.

8:Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy.
Authors:Piltin MA, Hoskin TL, Day CN, Shumway DA, Habermann EB, Davis J, Boughey JC
Institution:Department of Surgery, Mayo Clinic, Rochester, MN, USA. Rochester, MN, USA. Rochester, MN, USA. Rochester, MN, USA.
Journal:Ann Surg Oncol. 2021 Aug;28(8):4294-4303. doi: 10.1245/s10434-020-09517-z. Epub 2021 Jan 18.

9:Management of ipsilateral breast tumor recurrence following breast conservation surgery: a comparative study of re-conservation vs mastectomy.
Authors:Van den Bruele AB, Chen I, Sevilimedu V, Le T, Morrow M, Braunstein LZ, Cody HS 3rd
Institution:Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. codyh@mskcc.org.
Journal:Breast Cancer Res Treat. 2021 May;187(1):105-112. doi: 10.1007/s10549-020-06080-9. Epub 2021 Jan 12.

10:Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
Authors:Byng D, Retèl VP, Schaapveld M, Wesseling J, van Harten WH
Institution:Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. d.byng@nki.nl.
Journal:Breast Cancer Res Treat. 2021 May;187(1):187-196. doi: 10.1007/s10549-020-06042-1. Epub 2021 Jan 3.

11:Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
Authors:De Rose F, De Santis MC, Meduri B, Franzese C, Franceschini D, Franco P, Pasinetti N, Lancellotta V, Giacobazzi P, La Rocca E, D'Angelo E, Lozza L, Livi L, Meattini I, Scorsetti M
Institution:Radiotherapy and Radiosurgery Department, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milano, Italy.
Journal:J Cancer Res Clin Oncol. 2021 Jul;147(7):2069-2077. doi: 10.1007/s00432-020-03483-5. Epub 2021 Jan 2.

12:Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors.
Authors:Venkatesh SL, Oseni TO, Bahl M
Institution:Massachusetts General Hospital, Department of Radiology, 55 Fruit Street, WAC 240, Boston, MA 02114, USA. Electronic address: mbahl1@mgh.harvard.edu.
Journal:Clin Imaging. 2021 May;73:101-107. doi: 10.1016/j.clinimag.2020.11.050. Epub 2020 Dec 3.

13:Management of ductal carcinoma in situ with accelerated partial breast irradiation brachytherapy: Implications for guideline expansion.
Authors:Mills MN, Russo NW, Nanda RH, Wilson JP, Altoos TA, Caldwell DL, Stout LL, Dube S, Blumencranz PW, Allen KG, Diaz R
Institution:Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Institute, Tampa, FL. FL. FL. FL. Institute, Tampa, FL. Electronic address: Roberto.Diaz@moffitt.org.
Journal:Brachytherapy. 2021 Mar-Apr;20(2):345-352. doi: 10.1016/j.brachy.2020.11.002. Epub 2020 Dec 11.

14:Similar rates of residual disease in patients with DCIS within 2 mm of lumpectomy margin regardless of the presence of invasive carcinoma.
Authors:Kelly BN, Kantor O, Tang R, Coopey SB, Smith BL, Lanahan CR, Korotkin JE, Specht MC
Institution:Division of Surgical Oncology, Massachusetts General Hospital, Yawkey 7, 55 Fruit Street, Boston, MA, 02114, USA. mspecht@mgh.harvard.edu.
Journal:Breast Cancer Res Treat. 2021 Apr;186(3):807-814. doi: 10.1007/s10549-020-06026-1. Epub 2020 Nov 28.

15:Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era.
Authors:ElSherif AS, Tu C, Valente SA
Institution:Division of Breast Surgery, Department of General Surgery, Cleveland Clinic, Cleveland, OH, USA. Electronic address: valents3@ccf.org.
Journal:Am J Surg. 2021 Mar;221(3):521-524. doi: 10.1016/j.amjsurg.2020.11.012. Epub 2020 Nov 9.

16:Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes.
Authors:Halasz SR, O'Keefe T, Wallace AM, Blair SL
Institution:Department of Surgery, University of California San Diego, 9300 Campus Point Drive, #7220, La Jolla, CA, 92037, USA. Division of Breast Surgery and The Comprehensive Breast Health Center, University of California San Diego, Mailbox 0819, 3855 Health Sciences Dr, La Jolla, CA, 92037, USA. slblair@health.ucsd.edu.
Journal:Breast Cancer Res Treat. 2021 Apr;186(2):551-559. doi: 10.1007/s10549-020-06014-5. Epub 2020 Nov 12.

17:Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.
Authors:Lamb LR, Mercaldo S, Oseni TO, Bahl M
Institution:Division of Breast Imaging, Department of Radiology, Massachusetts General Hospital, Boston, MA, USA. mbahl1@mgh.harvard.edu.
Journal:Ann Surg Oncol. 2021 Mar;28(3):1390-1397. doi: 10.1245/s10434-020-09101-5. Epub 2020 Sep 10.

18:Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
Authors:Grimm LJ, Neely B, Hou R, Selvakumaran V, Baker JA, Yoon SC, Ghate SV, Walsh R, Litton TP, Devalapalli A, Kim C, Soo MS, Hyslop T, Hwang ES, Lo JY
Institution:Department of Diagnostic Radiology, Duke University Medical Center, 2301 Erwin Rd, Box 3808, Durham, NC 27710. Durham, NC. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Box 3808, Durham, NC 27710. Durham, NC. Box 3808, Durham, NC 27710.
Journal:AJR Am J Roentgenol. 2021 Apr;216(4):903-911. doi: 10.2214/AJR.20.23679. Epub 2021 Feb 3.

For a FREE PREVIEW of the Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast...
at a Special 20% Discount


Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast

Updated: July 1, 2021
188 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

DC33942907

Coupon Expires: November 17, 2021



What Our Customers Are Saying...

"The MediFocus Guidebook on DCIS was more than adequate for my research on this condition and I would recommend it to anyone wanting the "whole picture". Thank you for providing this excellent service."
C.M.
Los Angeles, California


"At a very difficult time, your MediFocus Guidebook on Ductal Carcinoma in Situ helped our family make informed decisions. Thank you for your help!"
M.A.L.
Metarie, Louisiana


"I was recently diagnosed with DCIS and was looking everywhere for information to get myself educated. The MediFocus Guidebook was very helpful in clarifying everything for me. The information is so well organized that it makes it easy to read and understand. I feel much better now that I've read this Guidebook and have a clearer understanding of the issues that I face. I highly recommend this Guidebook to anyone seeking to understand DCIS."
C.G.
Ft. Lauderdale, Florida



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2021 Medifocus, Inc. All rights reserved.